Calenda V - Search Results

1

Experimental gene therapy: the transfer of Tat-inducible interferon genes protects human cells against HIV-1 challenge in vitro and in vivo in severe combined immunodeficient mice.

Sanhadji K, Leissner P, Firouzi R, Pelloquin F, Kehrli L, Marigliano M, Calenda V, Ottmann M, Tardy JC, Mehtali M, Touraine JL. Sanhadji K, et al. Among authors: calenda v. AIDS. 1997 Jul;11(8):977-86. doi: 10.1097/00002030-199708000-00005. AIDS. 1997. PMID: 9223731

2

Gene therapy for HIV infection.

Calenda V, Leissner P, Marigliano M, Mehtali M. Calenda V, et al. Hematol Cell Ther. 1996 Apr;38(2):211-3. doi: 10.1007/s00282-996-0211-9. Hematol Cell Ther. 1996. PMID: 8932008 Review. No abstract available.

3

[In vitro and in vivo inhibition of HIV1 replication by retroviral transfer of interferon alpha, beta, or gamma genes: application to gene therapy of AIDS].

Leissner P, Calenda V, Marigliano M, Sanhadji K, Touraine JL, Pavirani A, Mehtali M. Leissner P, et al. Among authors: calenda v. Ann Biol Clin (Paris). 1998 Mar-Apr;56(2):167-73. Ann Biol Clin (Paris). 1998. PMID: 9754242 Free article. Review. French.

4

Adenovirus-mediated delivery of antiangiogenic genes as an antitumor approach.

Régulier E, Paul S, Marigliano M, Kintz J, Poitevin Y, Ledoux C, Roecklin D, Cauet G, Calenda V, Homann HE. Régulier E, et al. Among authors: calenda v. Cancer Gene Ther. 2001 Jan;8(1):45-54. doi: 10.1038/sj.cgt.7700278. Cancer Gene Ther. 2001. PMID: 11219493

5

Severe in vitro inhibition of erythropoiesis and transient stimulation of granulopoiesis after bone-marrow infection with eight different HIV-2 isolates.

Calenda V, Chermann JC. Calenda V, et al. AIDS. 1992 Sep;6(9):943-8. doi: 10.1097/00002030-199209000-00005. AIDS. 1992. PMID: 1388905

6

HIV Tat protein potentiates in vitro granulomonocytic progenitor cell growth.

Calenda V, Chermann JC. Calenda V, et al. Eur J Haematol. 1995 Mar;54(3):180-5. doi: 10.1111/j.1600-0609.1995.tb00213.x. Eur J Haematol. 1995. PMID: 7536687

7

Modulation of normal human erythropoietic progenitor cells in long-term liquid cultures after HIV-1 infection.

Calenda V, Sebahoun G, Chermann JC. Calenda V, et al. AIDS Res Hum Retroviruses. 1992 Jan;8(1):61-7. doi: 10.1089/aid.1992.8.61. AIDS Res Hum Retroviruses. 1992. PMID: 1736941

8

Involvement of HIV nef protein in abnormal hematopoiesis in AIDS: in vitro study on bone marrow progenitor cells.

Calenda V, Graber P, Delamarter JF, Chermann JC. Calenda V, et al. Eur J Haematol. 1994 Feb;52(2):103-7. doi: 10.1111/j.1600-0609.1994.tb01294.x. Eur J Haematol. 1994. PMID: 8119379

9

Special lectures VIII. AIDS.

Chermann JC, Fantini J, Calenda V, Silvy F, Hirsch I. Chermann JC, et al. Among authors: calenda v. AIDS Res Hum Retroviruses. 1992 May;8(5):711-8. AIDS Res Hum Retroviruses. 1992. PMID: 1515221 Review. No abstract available.

10

Effects of thymus humoral factor gamma-2 (THF gamma 2) on lymphohaematopoietic progenitor cells: an in vitro study.

Calenda V, Silvy F, Chermann JC. Calenda V, et al. Res Immunol. 1993 Jul-Sep;144(6-7):395-406. doi: 10.1016/0923-2494(93)80123-g. Res Immunol. 1993. PMID: 8303059

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters